Administration of anti-L-selectin (CD62L) mAb to neonatal nonobese diabetic (NOD) mice mediates long term protection against the development of insulitis and overt diabetes. These results suggested that CD62L has a key role in the general function of β cell-specific T cells. To further examine the role of CD62L in the development of type 1 diabetes, NOD mice lacking CD62L were established. The onset and frequency of overt diabetes were equivalent among CD62L+/+, CD62L+/−, and CD62L−/− NOD littermates. Furthermore, patterns of T cell activation, migration, and β cell-specific reactivity were similar in NOD mice of all three genotypes. Adoptive transfer experiments with CD62L−/− CD4+ T cells prepared from BDC2.5 TCR transgenic mice revealed no apparent defects in migration to pancreatic lymph nodes, proliferation in response to β cell Ag, or induction of diabetes in NOD.scid recipients. In conclusion, CD62L expression is not essential for the development of type 1 diabetes in NOD mice.
CITATION STYLE
Friedline, R. H., Wong, C. P., Steeber, D. A., Tedder, T. F., & Tisch, R. (2002). L-Selectin Is Not Required for T Cell-Mediated Autoimmune Diabetes. The Journal of Immunology, 168(6), 2659–2666. https://doi.org/10.4049/jimmunol.168.6.2659
Mendeley helps you to discover research relevant for your work.